Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	35	non-cytoplasmic
36	60	transmembrane
61	93	cytoplasmic
94	119	transmembrane
120	125	non-cytoplasmic
126	144	transmembrane
145	152	cytoplasmic
153	177	transmembrane
178	202	non-cytoplasmic
203	222	transmembrane
223	233	cytoplasmic
234	256	transmembrane
257	279	non-cytoplasmic
280	311	transmembrane
312	331	cytoplasmic
332	352	transmembrane
353	357	non-cytoplasmic
358	382	transmembrane
383	396	cytoplasmic
397	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	448	cytoplasmic
449	469	transmembrane
470	475	non-cytoplasmic

Input:
>PP_1002
MSDSSGKLKLGALVALVVGSMIGGGIFSLPQNMAASAGVGAVLIGWAITAVGMLTLAFVF
QTLANRKPDLDGGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFFPIF
GEGNTPAAIIGASILLWAVHFLVLRGIKEAAFINLVTTVAKVVPLVLFALICLFAFRLDI
FTADIWAMGTPELGSVMNQVRNMMLVTVWVFIGIEGASIFSARAEKRTDVGKATVIGFVT
VLLFLVLVNVLSLGIMTQPELAKLQNPSMAAVLEHVVGHWGAVLISVGLVISLLGALLSW
VLLCAEIMFAAAKDHTMPEFLRRENAKQVPANALWLTNAMVQIFLVITLFSSSTYLSLIY
LATSMILVPYLWSAAYAFLLALRSETYEQALAERKKDLIIGGIALLYAIWLLYAGGVKYL
LLSALLYAPGAILFAKAKREVGKPVFTNVEKLIFAAVVIGALVAAYGLYDGFLTL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server